Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Total 13F shares
-
10,443,495
-
Share change
-
+246,790
-
Total reported value
-
$530,912,559
-
Put/Call ratio
-
263%
-
Price per share
-
$50.85
-
Number of holders
-
122
-
Value change
-
+$20,770,064
-
Number of buys
-
59
-
Number of sells
-
62
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2014
As of 31 Dec 2014 ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) had 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,443,495 shares of stock of the company.
Largest 10 holders included FMR LLC, Consonance Capital Management LP, EAGLE ASSET MANAGEMENT INC, Apex Capital Management, State Street Corp, BlackRock Fund Advisors, VANGUARD GROUP INC, Marshall Wace LLP, BlackRock Institutional Trust Company, N.A., and WALL STREET ASSOCIATES.
This table shows 122 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.